
Please try another search
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China. The company’s medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company’s products in development include small RNA drugs, such as FB7011/FB7013/FB7014 to treat IgA nephropathy, FB7022/FB7021 for dyslipidemia, and FB7012/FB7041/FB7031/FB7032 for various other diseases, including hyperuricemia and gout, tumors, and metabolic-associated fatty liver diseases; FB4001, to treat patients with osteoporosis or high risk of fracture; and FB3002, for the treatment of pain in muscles, bones, and joints. Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.
Name | Age | Since | Title |
---|---|---|---|
Changjin Wang | 67 | 2013 | MD, CBO & Director |
Rongjian Lu | 63 | 2013 | CTO & Director |
Dong Xie | 59 | 2002 | Founder, Chairman, President & Chief Scientific Officer |
Yuantao Cao | 44 | 2018 | Supervisor |
Yuting Zhu | 36 | 2019 | Supervisor & Deputy GM Administrative Director |
Kai Chen | 66 | 2019 | Independent Director |
Zhi Zhong Jiang | 43 | 2016 | Chairman of the Supervisory Board & Purchasing Director |
Chi Kit Ng | 52 | 2019 | Independent Director |
Yuanfan Chen | 39 | 2024 | Director |
Guangji Wang | 72 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review